Compile Data Set for Download or QSAR
maximum 50k data
Found 88 with Last Name = 'bouchard' and Initial = 'pj'
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083811(3-({1-[3-(1H-Imidazol-2-ylamino)-propyl]-1H-indazo...)
Affinity DataIC50:  2.30nMAssay Description:Inhbitory activity against beta3-transfected 293 cells using alpha-V beta-3 antagonism assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083839(2-Benzyloxycarbonylamino-3-({1-[3-(4,5-dihydro-1H-...)
Affinity DataIC50:  3.80nMAssay Description:Inhbition of Vitronectin receptor (alpha V beta 3) bindingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083823(3-({1-[3-(1H-Imidazol-2-ylamino)-propyl]-1H-indazo...)
Affinity DataIC50:  4.70nMAssay Description:Inhbitory activity against beta3-transfected 293 cells using alpha-V beta-3 antagonism assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083797(2-(3,5-Dimethyl-biphenyl-4-sulfonylamino)-3-({1-[3...)
Affinity DataIC50:  4.90nMAssay Description:Inhbitory activity against beta3-transfected 293 cells using alpha-V beta-3 antagonism assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083803(2-Benzyloxycarbonylamino-3-({1-[3-(4,5-dihydro-1H-...)
Affinity DataIC50:  7.30nMAssay Description:Inhbition of Vitronectin receptor (alpha V beta 3) bindingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083836(2-(2,6-Dichloro-benzenesulfonylamino)-3-({1-[3-(1H...)
Affinity DataIC50:  8.5nMAssay Description:Inhbitory activity against beta3-transfected 293 cells using alpha-V beta-3 antagonism assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083807(2-(3,4-Dichloro-benzenesulfonylamino)-3-({1-[3-(1H...)
Affinity DataIC50:  10nMAssay Description:Inhbitory activity against beta3-transfected 293 cells using alpha-V beta-3 antagonism assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083810(2-(2,6-Dimethyl-benzenesulfonylamino)-3-({1-[3-(1H...)
Affinity DataIC50:  10nMAssay Description:Inhbitory activity against beta3-transfected 293 cells using alpha-V beta-3 antagonism assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083837(2-(4-Chloro-benzenesulfonylamino)-3-({1-[3-(1H-imi...)
Affinity DataIC50:  10nMAssay Description:Inhbitory activity against beta3-transfected 293 cells using alpha-V beta-3 antagonism assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083836(2-(2,6-Dichloro-benzenesulfonylamino)-3-({1-[3-(1H...)
Affinity DataIC50:  12nMAssay Description:Inhibition of aggregation of human gel-purified platelets (GPIIbIIIa GPP)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083812(3-({1-[3-(1H-Imidazol-2-ylamino)-propyl]-1H-indazo...)
Affinity DataIC50:  13nMAssay Description:Inhbitory activity against beta3-transfected 293 cells using alpha-V beta-3 antagonism assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083833(3-({1-[3-(1H-Imidazol-2-ylamino)-propyl]-1H-indazo...)
Affinity DataIC50:  16nMAssay Description:Inhbitory activity against beta3-transfected 293 cells using alpha-V beta-3 antagonism assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083811(3-({1-[3-(1H-Imidazol-2-ylamino)-propyl]-1H-indazo...)
Affinity DataIC50:  21nMAssay Description:Inhibition of aggregation of human gel-purified platelets (GPIIbIIIa GPP)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083802(3-({1-[3-(1H-Imidazol-2-ylamino)-propyl]-1H-indazo...)
Affinity DataIC50:  25nMAssay Description:Inhbitory activity against beta3-transfected 293 cells using alphaV-beta3 antagonism assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083793(2-Benzyloxycarbonylamino-3-({2-[3-(4,5-dihydro-1H-...)
Affinity DataIC50:  25nMAssay Description:Inhbition of Vitronectin receptor (alpha V beta 3) bindingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083809(3-({1-[3-(1H-Imidazol-2-ylamino)-propyl]-1H-indazo...)
Affinity DataIC50:  26nMAssay Description:Inhbitory activity against beta3-transfected 293 cells using alpha-V beta-3 antagonism assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083814(3-({1-[3-(1,4,5,6-Tetrahydro-pyrimidin-2-ylamino)-...)
Affinity DataIC50:  28nMAssay Description:Inhibition of adhesion of integrin beta3-transfected HEK293 cells to fibrinogenMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083785(3-({5-[3-(1H-Imidazol-2-ylcarbamoyl)-propyl]-4,5-d...)
Affinity DataIC50:  31nMAssay Description:Inhbitory activity against beta3-transfected 293 cells using alpha-V beta-3 antagonism assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083799(2-Benzenesulfonylamino-3-({1-[3-(1H-imidazol-2-yla...)
Affinity DataIC50:  34nMAssay Description:Inhibition of aggregation of human gel-purified platelets (GPIIbIIIa GPP)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083805(2-(Biphenyl-4-sulfonylamino)-3-({1-[3-(1H-imidazol...)
Affinity DataIC50:  35nMAssay Description:Inhbitory activity against beta3-transfected 293 cells using alpha-V beta-3 antagonism assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083812(3-({1-[3-(1H-Imidazol-2-ylamino)-propyl]-1H-indazo...)
Affinity DataIC50:  39nMAssay Description:Inhibition of aggregation of human gel-purified platelets (GPIIbIIIa GPP)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083799(2-Benzenesulfonylamino-3-({1-[3-(1H-imidazol-2-yla...)
Affinity DataIC50:  44nMAssay Description:Inhbitory activity against beta3-transfected 293 cells using alpha-V beta-3 antagonism assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083813(3-({1-[3-(Pyridin-2-ylamino)-propyl]-1H-indazole-5...)
Affinity DataIC50:  48nMAssay Description:Inhbitory activity against beta3-transfected 293 cells using alpha-V beta-3 antagonism assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083801(2-Benzyloxycarbonylamino-3-({1-[2-(4,5-dihydro-1H-...)
Affinity DataIC50:  51nMAssay Description:Inhbition of Vitronectin receptor (alpha V beta 3) bindingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083816(3-({1-[3-(1H-Imidazol-2-ylamino)-propyl]-1H-indazo...)
Affinity DataIC50:  52nMAssay Description:Inhbitory activity against beta3-transfected 293 cells using alpha-V beta-3 antagonism assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083828(2-Benzyloxycarbonylamino-3-({2-[3-(4,5-dihydro-1H-...)
Affinity DataIC50:  55nMAssay Description:Inhbition of Vitronectin receptor (alpha V beta 3) bindingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083794(3-({1-[2-(1H-Imidazol-2-ylcarbamoyl)-ethyl]-1H-ind...)
Affinity DataIC50:  56nMAssay Description:Inhbitory activity against beta3-transfected 293 cells using alpha-V beta-3 antagonism assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083821(3-({1-[3-(4,5-Dihydro-1H-imidazol-2-ylamino)-propy...)
Affinity DataIC50:  57nMAssay Description:Inhibition of aggregation of human gel-purified platelets (GPIIbIIIa GPP)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083814(3-({1-[3-(1,4,5,6-Tetrahydro-pyrimidin-2-ylamino)-...)
Affinity DataIC50:  66nMAssay Description:Inhibition of aggregation of human gel-purified platelets (GPIIbIIIa GPP)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083821(3-({1-[3-(4,5-Dihydro-1H-imidazol-2-ylamino)-propy...)
Affinity DataIC50:  70nMAssay Description:Inhibition of adhesion of integrin beta3-transfected HEK293 cells to fibrinogenMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083832(2-Benzyloxycarbonylamino-3-({1-[3-(1H-imidazol-2-y...)
Affinity DataIC50:  74nMAssay Description:Inhbitory activity against beta3-transfected 293 cells using alpha-V beta-3 antagonism assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083810(2-(2,6-Dimethyl-benzenesulfonylamino)-3-({1-[3-(1H...)
Affinity DataIC50:  74nMAssay Description:Inhibition of aggregation of human gel-purified platelets (GPIIbIIIa GPP)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083797(2-(3,5-Dimethyl-biphenyl-4-sulfonylamino)-3-({1-[3...)
Affinity DataIC50:  74nMAssay Description:Inhibition of aggregation of human gel-purified platelets (GPIIbIIIa GPP)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083823(3-({1-[3-(1H-Imidazol-2-ylamino)-propyl]-1H-indazo...)
Affinity DataIC50:  81nMAssay Description:Inhibition of aggregation of human gel-purified platelets (GPIIbIIIa GPP)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083833(3-({1-[3-(1H-Imidazol-2-ylamino)-propyl]-1H-indazo...)
Affinity DataIC50:  83nMAssay Description:Inhibition of aggregation of human gel-purified platelets (GPIIbIIIa GPP)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083798(2-Benzenesulfonylamino-3-({1-[3-(pyridin-2-ylamino...)
Affinity DataIC50:  120nMAssay Description:Inhbitory activity against beta3-transfected 293 cells using alpha-V beta-3 antagonism assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083831(2-(4-tert-Butyl-benzenesulfonylamino)-3-({1-[3-(1H...)
Affinity DataIC50:  120nMAssay Description:Inhbitory activity against beta3-transfected 293 cells using alpha-V beta-3 antagonism assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083805(2-(Biphenyl-4-sulfonylamino)-3-({1-[3-(1H-imidazol...)
Affinity DataIC50:  130nMAssay Description:Inhibition of aggregation of human gel-purified platelets (GPIIbIIIa GPP)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083834(2-(4-Acetylamino-benzenesulfonylamino)-3-({1-[3-(1...)
Affinity DataIC50:  150nMAssay Description:Inhbitory activity against beta3-transfected 293 cells using alpha-V beta-3 antagonism assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083804(3-[1-[3-(N-Pyridin-2ylamino)propyl]indazol-5-ylcar...)
Affinity DataIC50:  170nMAssay Description:Inhbitory activity against beta3-transfected 293 cells using alpha-V beta-3 antagonism assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083813(3-({1-[3-(Pyridin-2-ylamino)-propyl]-1H-indazole-5...)
Affinity DataIC50:  220nMAssay Description:Inhibition of aggregation of human gel-purified platelets (GPIIbIIIa GPP)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083815(2-Isobutoxycarbonylamino-3-({1-[3-(pyridin-2-ylami...)
Affinity DataIC50:  240nMAssay Description:Inhbitory activity against beta3-transfected 293 cells using alpha-V beta-3 antagonism assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083795(2-Benzyloxycarbonylamino-3-({1-[4-(4,5-dihydro-1H-...)
Affinity DataIC50:  250nMAssay Description:Inhbition of Vitronectin receptor (alpha V beta 3) bindingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083837(2-(4-Chloro-benzenesulfonylamino)-3-({1-[3-(1H-imi...)
Affinity DataIC50:  260nMAssay Description:Inhibition of aggregation of human gel-purified platelets (GPIIbIIIa GPP)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50408870(CHEMBL2111217)
Affinity DataIC50:  290nMAssay Description:Inhbitory activity against beta3-transfected 293 cells using alpha-V beta-3 antagonism assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083798(2-Benzenesulfonylamino-3-({1-[3-(pyridin-2-ylamino...)
Affinity DataIC50:  290nMAssay Description:Inhibition of aggregation of human gel-purified platelets (GPIIbIIIa GPP)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083817(2-Benzyloxycarbonylamino-3-({1-[3-(pyridin-2-ylami...)
Affinity DataIC50:  300nMAssay Description:Inhbitory activity against beta3-transfected 293 cells using alpha-V beta-3 antagonism assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083800(2-(Butane-1-sulfonylamino)-3-({1-[3-(pyridin-2-yla...)
Affinity DataIC50:  360nMAssay Description:Inhbitory activity against beta3-transfected 293 cells using alpha-V beta-3 antagonism assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083829(3-[1-[3-(N-Pyridin-2ylamino)propyl]indazol-5-ylcar...)
Affinity DataIC50:  360nMAssay Description:Inhbitory activity against beta3-transfected 293 cells using alpha-V beta-3 antagonism assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083834(2-(4-Acetylamino-benzenesulfonylamino)-3-({1-[3-(1...)
Affinity DataIC50:  400nMAssay Description:Inhibition of aggregation of human gel-purified platelets (GPIIbIIIa GPP)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Displayed 1 to 50 (of 88 total ) | Next | Last >>
Jump to: